Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs

被引:32
作者
Liu, Yizhong [1 ,2 ]
Sakolish, Courtney [1 ,2 ]
Chen, Zunwei [1 ,2 ]
Phan, Duc T. T. [3 ]
Bender, R. Hugh F. [3 ]
Hughes, Christopher C. W. [3 ,4 ]
Rusyn, Ivan [1 ,2 ]
机构
[1] Interdisciplinary Fac Toxicol, College Stn, TX 77843 USA
[2] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[4] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Microphysiological system; Drug safety evaluation; Tissue chip; ENDOTHELIAL-CELLS; MOLECULAR-MECHANISMS; LUMEN FORMATION; ANGIOGENESIS; IDENTIFICATION; DYSFUNCTION; BLOOD;
D O I
10.1016/j.tox.2020.152601
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Angiogenesis is a complex process that is required for development and tissue regeneration and it may be affected by many pathological conditions. Chemicals and drugs can impact formation and maintenance of the vascular networks; these effects may be both desirable (e.g., anti-cancer drugs) or unwanted (e.g., side effects of drugs). A number of in vivo and in vitro models exist for studies of angiogenesis and endothelial cell function, including organ on a chip microphysiological systems. An arrayed organ on a chip platform on a 96-well plate footprint that incorporates perfused microvessels, with and without tumors, was recently developed and it was shown that survival of the surrounding tissue was dependent on delivery of nutrients through the vessels. Here we describe a technology transfer of this complex microphysiological model between laboratories and demonstrate that reproducibility and robustness of these tissue chip-enabled experiments depend primarily on the source of the endothelial cells. The model was highly reproducible between laboratories and was used to demonstrate the advantages of the perfusable vascular networks for drug safety evaluation. As a proof-of-concept, we tested Fluorouracil (1-1,000 mu M), Vincristine (1-1,000 nM), and Sorafenib (0.1-100 mu M), in the perfusable and non-perfusable micro-organs, and in a colon cancer-containing micro-tumor model. Tissue chip experiments were compared to the traditional monolayer cultures of endothelial or tumor cells. These studies showed that human in vitro vascularized micro-organ and micro-tumor models are reproducible organ on a chip platforms for studies of anticancer drugs. The data from the 3D models confirmed advantages of the physiological environment as compared to 2D cell cultures. We demonstrated how these models can be translated into practice by verifying that the endothelial cell source and passage are critical elements for establishing a perfusable model.
引用
收藏
页数:12
相关论文
共 49 条
  • [1] A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells
    Atchison, Leigh
    Zhang, Haoyue
    Cao, Kan
    Truskey, George A.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [2] The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
    Barillari, Giovanni
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Molecular mechanisms and clinical applications of angiogenesis
    Carmeliet, Peter
    Jain, Rakesh K.
    [J]. NATURE, 2011, 473 (7347) : 298 - 307
  • [4] AGING IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION IN HEALTHY-MEN YEARS BEFORE THE AGE-RELATED DECLINE IN WOMEN
    CELERMAJER, DS
    SORENSEN, KE
    SPIEGELHALTER, DJ
    GEORGAKOPOULOS, D
    ROBINSON, J
    DEANFIELD, JE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (02) : 471 - 476
  • [5] NADPH Oxidase 4 Promotes Endothelial Angiogenesis Through Endothelial Nitric Oxide Synthase Activation
    Craige, Siobhan M.
    Chen, Kai
    Pei, Yongmei
    Li, Chunying
    Huang, Xiaoyun
    Chen, Christine
    Shibata, Rei
    Sato, Kaori
    Walsh, Kenneth
    Keaney, John F., Jr.
    [J]. CIRCULATION, 2011, 124 (06) : 731 - U193
  • [6] Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells
    Dewberry, RM
    Crossman, DC
    Francis, SE
    [J]. CIRCULATION RESEARCH, 2003, 92 (12) : 1285 - 1287
  • [7] Vascular endothelial senescence: from mechanisms to pathophysiology
    Erusalimsky, Jorge D.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2009, 106 (01) : 326 - 332
  • [8] Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective
    Ewart, Lorna
    Fabre, Kristin
    Chakilam, Ananthsrinivas
    Dragan, Yvonne
    Duignan, David B.
    Eswaraka, Jeetu
    Gan, Jinping
    Guzzie-Peck, Peggy
    Otieno, Monicah
    Jeong, Claire G.
    Keller, Douglas A.
    de Morais, Sonia M.
    Phillips, Jonathan A.
    Proctor, William
    Sura, Radhakrishna
    Van Vleet, Terry
    Watson, David
    Will, Yvonne
    Tagle, Danilo
    Berridge, Brian
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 242 (16) : 1579 - 1585
  • [9] Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo
    Gebala, Veronique
    Collins, Russell
    Geudens, Ilse
    Phng, Li-Kun
    Gerhardt, Holger
    [J]. NATURE CELL BIOLOGY, 2016, 18 (04) : 443 - +
  • [10] Cardiovascular Effects of Polychlorinated Biphenyls and Their Major Metabolites
    Grimm, Fabian A.
    Klaren, William D.
    Li, Xueshu
    Lehmler, Hans-Joachim
    Karmakar, Moumita
    Robertson, Larry W.
    Chiu, Weihsueh A.
    Rusyn, Ivan
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2020, 128 (07) : 1 - 13